Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence,Knowledge and Attitude of HIV /AIDS in Luxor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03485599
Recruitment Status : Not yet recruiting
First Posted : April 2, 2018
Last Update Posted : April 2, 2018
Sponsor:
Information provided by (Responsible Party):
Zienab Gamea, Assiut University

Brief Summary:

Human immunodeficiency virus infection is a global pandemic problem. About 35.3 million infected people in the world, so causing a great social, economical, political and cultural problems worldwide.

In 1986 Egypt's first AIDS case was discovered , since then the number of infected cases cases are increasing.According to United Nations 2016 statistics, there are about 11,000 infected people living with Human immunodeficiency virus in Egypt.


Condition or disease Intervention/treatment
HIV/AIDS Diagnostic Test: ELIZA , Westron blot

Detailed Description:

Human immunodeficiency virus is a lentivirus that causes the infection and over time leading to Acquired immunodeficiency syndrome.

The virus spread primarily by unprotected sex including vaginal, anal and oral sex, contaminated blood transfusions, infected needles, and from mother to child during pregnancy, delivery, or from milk during breastfeeding.

In 1986 Egypt's first AIDS case was discovered , since then the number of infected cases cases are increasing.According to United Nations 2016 statistics, there are about 11,000 infected people living with Human immunodeficiency virus in Egypt.

According to the National Aids Program, the primary mode of transmission is heterosexual intercourse, followed by homosexual intercourse , renal dialysis , and blood transfusion Others include street children, prisoners, and refugees, female sex workers, men have sex with men, and injecting drug users.

Human immunodeficiency virus related stigma and discrimination is a great barrier to effectively fighting the disease epidemic.

This study will assess prevalence, knowledge, attitudes of Human immunodeficiency virus and Acquired immunodeficiency syndrome people in Luxor Governorate in Upper Egypt.


Layout table for study information
Study Type : Observational
Estimated Enrollment : 400 participants
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Prevalence,Knowledge and Attitude of HIV /AIDS in Luxor
Estimated Study Start Date : January 2019
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : April 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS

Group/Cohort Intervention/treatment
HIV infected people
Blood samples will be taken and rapid HIV test by ELIZA will be done ,for positive cases Westron blot done
Diagnostic Test: ELIZA , Westron blot
Blood sample will be taken then rapid test by ELIZA will be done if positive then confirmatory test by Westron blot will be done




Primary Outcome Measures :
  1. knowledge score [ Time Frame: 20 mintues ]
    Questionnaire to define knowledge score of HIV/AIDS through an interview



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Community based cross sectional study will be done in Luxor,Data will be collected by physicians at the mobile Voluntary Confidential Counseling and Testing centers apart of National strategic plan , blood samples will be taken by laboratory technician,diagnostic tests will be done.
Criteria

Inclusion Criteria:

1-People living in Luxor. 2 Subjects of high risk groups as men have sex with men, children street, female sex workers.

3-People clinically diagnosed as HIV/AIDS. 4-People in contact with HIV/AIDS patients.

Exclusion Criteria:

1 - Subjects outside Luxor 2- People refused to consent 3- Mentally disordered patients


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03485599


Contacts
Layout table for location contacts
Contact: Hisham Zayan, Assistant 01223971409 hishamzayan@icloud.com
Contact: Yasmine Mostafa, Lecturer 01006033331 dr.yasminemostawfik@yahoo.com

Locations
Layout table for location information
Egypt
Faculty of Medicine Not yet recruiting
Assiut, Egypt, 71111
Contact: Amira El Gazar, lecturer    01008194433    Elgazzar44@yahoo.com   
Sponsors and Collaborators
Assiut University
Investigators
Layout table for investigator information
Study Director: Hisham Zayan, Assistant Assiut University

Publications of Results:
Layout table for additonal information
Responsible Party: Zienab Gamea, Principal Investigator, Assiut University
ClinicalTrials.gov Identifier: NCT03485599     History of Changes
Other Study ID Numbers: PKHIVL
First Posted: April 2, 2018    Key Record Dates
Last Update Posted: April 2, 2018
Last Verified: March 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No